Walleye Trading’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-45,348
| Closed | -$2.34M | – | 5801 |
|
|
2022
Q3 | $2.34M | Buy |
45,348
+28,299
| +166% | +$1.17M | 0.01% | 1574 |
|
|
2022
Q2 | $422K | Sell |
17,049
-5,052
| -23% | -$111K | ﹤0.01% | 3059 |
|
|
2022
Q1 | $554K | Sell |
22,101
-23,487
| -52% | -$660K | ﹤0.01% | 2794 |
|
|
2021
Q4 | $1.66M | Buy |
+45,588
| New | +$1.6M | 0.01% | 1798 |
|
|
2020
Q4 | – | Sell |
-2,162
| Closed | -$124K | – | 5063 |
|
|
2020
Q3 | $118K | Buy |
+2,162
| New | +$116K | ﹤0.01% | 3320 |
|
|
2019
Q2 | – | Sell |
-14,800
| Closed | -$206K | – | 4656 |
|
|
2019
Q1 | $206K | Buy |
+14,800
| New | +$169K | ﹤0.01% | 3002 |
|
|
2018
Q2 | – | Sell |
-14,400
| Closed | -$196K | – | 5027 |
|
|
2018
Q1 | $196K | Buy |
+14,400
| New | +$149K | ﹤0.01% | 3509 |
|
|
2017
Q3 | – | Sell |
-5,900
| Closed | -$55 | – | 4743 |
|
|
2017
Q2 | $55 | Sell |
5,900
-4,700
| -44% | -$34.5K | ﹤0.01% | 3852 |
|
|
2017
Q1 | $77 | Sell |
10,600
-32,700
| -76% | -$235K | ﹤0.01% | 3561 |
|
|
2016
Q4 | $320K | Buy |
+43,300
| New | +$312K | ﹤0.01% | 2446 |
|
Other funds holding CCXI
Walleye Trading's CCXI Position: Q4 2022 in Review
Walleye Trading sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 45,348 shares — an estimated $2.34M sold.
Walleye Trading first reported a position in CCXI in Q4 2016 and held it in 10 quarters. The position peaked at $2.34M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Walleye Trading reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Walleye Trading sold 45,348 ChemoCentryx, Inc. shares in Q4 2022, an estimated $2.34M.
- Walleye Trading first reported a position in ChemoCentryx, Inc. in Q4 2016 and held it in 10 quarters.
- Walleye Trading's ChemoCentryx, Inc. position peaked at $2.34M in Q3 2022.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Walleye Trading's 13F filing for Q4 2022, filed 14 Feb 2023.